×
About 8,006 results

ALLMedicine™ Vitiligo Center

Research & Reviews  3,835 results

Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage i...
https://doi.org/10.1111/bjd.19827
The British Journal of Dermatology; Cotter C, Kretz M et. al.

Mar 4th, 2021 - Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.|2021|Cotter C,Kretz M,Rajan N,|

Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental viti...
https://doi.org/10.1111/jocd.14041
Journal of Cosmetic Dermatology; Saleh R, Abd-Elaziz Ahmed A et. al.

Mar 3rd, 2021 - Topical tacrolimus is increasingly used nowadays in the treatment of vitiligo. We evaluated therapeutic outcomes of tacrolimus 0.03% in non-segmental vitiligo (NSV). Sixty-three patients with NSV were divided into groups A & B. Group A received 0....

A20 deficiency in myeloid cells deteriorates the onset of vitiligo in mice.
https://doi.org/10.1111/dth.14923
Dermatologic Therapy; Li H, Wang C et. al.

Mar 2nd, 2021 - Melanocyte-specific CD8+ T cells enrichment correlates with the severity of vitiligo, and the role of A20 derived from myeloid cells in the enrichment of pathogenic T cells is unknown. Premelanosome (PMEL)-specific transgenic CD8+ T cells were ado...

DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy.
https://doi.org/10.1111/dth.14921
Dermatologic Therapy; Salem RM, Abdelrahman AMN et. al.

Mar 1st, 2021 - Human beta defensin- 1(hBD-1); an antimicrobial peptide, has immune regulatory effects which may be involved in autoimmunity. The aims were to evaluate the association between defensin beta 1 (DEFB1) (-44 C/G) and (-20 G/A) gene polymorphisms with...

Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel mig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908664
BMC Surgery; Wang B, Sun J et. al.

Feb 27th, 2021 - Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk depositi...

see more →

Guidelines  3 results

Guidelines for the diagnosis and treatment of vitiligo in Japan.
https://doi.org/10.1111/1346-8138.12099
The Journal of Dermatology; Oiso N, Suzuki T et. al.

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
https://doi.org/10.1111/j.1365-2133.2012.11197.x
The British Journal of Dermatology; Taieb A, Alomar A et. al.

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Guideline for the diagnosis and management of vitiligo.
https://doi.org/10.1111/j.1365-2133.2008.08881.x
The British Journal of Dermatology; Gawkrodger DJ, Ormerod AD et. al.

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  3,919 results

Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage i...
https://doi.org/10.1111/bjd.19827
The British Journal of Dermatology; Cotter C, Kretz M et. al.

Mar 4th, 2021 - Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.|2021|Cotter C,Kretz M,Rajan N,|

Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental viti...
https://doi.org/10.1111/jocd.14041
Journal of Cosmetic Dermatology; Saleh R, Abd-Elaziz Ahmed A et. al.

Mar 3rd, 2021 - Topical tacrolimus is increasingly used nowadays in the treatment of vitiligo. We evaluated therapeutic outcomes of tacrolimus 0.03% in non-segmental vitiligo (NSV). Sixty-three patients with NSV were divided into groups A & B. Group A received 0....

A20 deficiency in myeloid cells deteriorates the onset of vitiligo in mice.
https://doi.org/10.1111/dth.14923
Dermatologic Therapy; Li H, Wang C et. al.

Mar 2nd, 2021 - Melanocyte-specific CD8+ T cells enrichment correlates with the severity of vitiligo, and the role of A20 derived from myeloid cells in the enrichment of pathogenic T cells is unknown. Premelanosome (PMEL)-specific transgenic CD8+ T cells were ado...

DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy.
https://doi.org/10.1111/dth.14921
Dermatologic Therapy; Salem RM, Abdelrahman AMN et. al.

Mar 1st, 2021 - Human beta defensin- 1(hBD-1); an antimicrobial peptide, has immune regulatory effects which may be involved in autoimmunity. The aims were to evaluate the association between defensin beta 1 (DEFB1) (-44 C/G) and (-20 G/A) gene polymorphisms with...

Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel mig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908664
BMC Surgery; Wang B, Sun J et. al.

Feb 27th, 2021 - Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk depositi...

see more →

News  227 results

Topical Corticosteroid and Home-based Narrowband UVB for Localised Vitiligo
https://www.medscape.com/viewarticle/938697

Oct 8th, 2020 - Takeaway Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent...

Narrowband UVB for Vitiligo Linked to Lower Fracture Risk
https://www.medscape.com/viewarticle/937667

Sep 20th, 2020 - NEW YORK (Reuters Health) - Vitiligo patients who receive long-term narrowband UVB phototherapy are at lower risk of major osteoporotic fractures, new research shows. "Systemic phototherapy to treat vitiligo can unexpectedly reduce the risk of fra...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Vitiligo tied to lower risk of internal malignancies
https://www.mdedge.com/dermatology/article/217491/pigmentation-disorders/vitiligo-tied-lower-risk-internal-malignancies?channel=39313
Bruce Jancin

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

Pembrolizumab-Induced Lobular Panniculitis in the Setting of Metastatic Melanoma
https://www.mdedge.com/dermatology/article/216730/melanoma/pembrolizumab-induced-lobular-panniculitis-setting-metastatic?channel=44
Caitlin M. Peterman, MD, Leslie Robinson-Bostom, MD et. al.

Feb 5th, 2020 - To the Editor: Pembrolizumab is an anti–programmed death receptor 1 humanized monoclonal antibody used for treating advanced or metastatic melanoma. 1 It is associated with several immune-related adverse events because it blocks a T-cell receptor c.

see more →

Patient Education  19 results see all →